Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2026 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of ServiceAcceptable Use
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to Reports
Fundraising

Third Harmonic Bio

Third Harmonic Bio Raises $200M in Series C

325 Vassar Street, Cambridge, MA 02139November 23, 20242 min read
Employees
100+

Third Harmonic Bio Raises $200M in Series C


Third Harmonic Bio has successfully raised $200M in a Series C at a $750M valuation led by ARCH Venture Partners, Polaris Partners, RA Capital Management, GV.


Company Overview


Third Harmonic Bio is a Biotech company headquartered in 325 Vassar Street, Cambridge, MA 02139, founded in 2019 with 100+ employees.


Dicerna-based RNAi therapeutics


Fundraising Details


  • Amount Raised: $200M
  • Round Type: Series C
  • Valuation: $750M
  • Date: 2024-11-23
  • Investors: ARCH Venture Partners, Polaris Partners, RA Capital Management, GV

About Third Harmonic Bio


Dicerna-based RNAi therapeutics The company is positioned in the Biotech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 325 Vassar Street, Cambridge, MA 02139
  • Founded: 2019
  • Team Size: 100+
  • Industry: Biotech

What This Means


This funding round demonstrates strong investor confidence in Third Harmonic Bio's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Third Harmonic Bio's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $750M valuation marks an important milestone for Third Harmonic Bio, positioning the company among notable players in the Biotech industry.


Looking Ahead


With this new capital, Third Harmonic Bio is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-11-23. For more information about Third Harmonic Bio, visit their headquarters at 325 Vassar Street, Cambridge, MA 02139.

Company Info

Headquarters
325 Vassar Street, Cambridge, MA 02139
Founded
2019
Team Size
100+

Topics

Fundraising(2912)Series C(299)BiotechThird Harmonic Bio

Share

Related Reports

Fundraising
Swap

Swap Raises $100M Series C | Unified Commerce Platform

Commerce operating system Swap secures $100 million Series C just six months after Series B.

SalesTools Research
SalesTools Research
Jan 10, 2026
0 min readβ€’$100M
Fundraising
Corsera Health

Corsera Health Raises $80M Series A | Once-Yearly Cardiovascular RNAi

Biotech startup Corsera Health secures $80 million Series A for once-yearly RNAi cardiovascular treatments.

SalesTools Research
SalesTools Research
Jan 10, 2026
0 min readβ€’$80M
Fundraising
Rain

Rain Raises $250M Series C | Stablecoin Payment Infrastructure

Crypto infrastructure company Rain secures $250 million Series C led by ICONIQ for stablecoin payments.

SalesTools Research
SalesTools Research
Jan 9, 2026
0 min readβ€’$250M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free